Top Anti Cancer Imported Medicine Drugs in India - Pharama Five

Pharma Five is a registered firm based in India. We specialize in Named Patient Imports, Imported cancer drugs, Imported medicines in india.

Contact Us Pharma Five Door No. 74, Old No. 26, Fagun Mansion, 3rd Floor, Ethiraj Salai, Egmore, Chennai - 600008 +916374297988 info@pharmafive.org
Buy Rozlytrek (Entrectinib) Medicine in India

Rozlytrek (Entrectinib)

Medicine name : Rozlytrek

Generic name : Entrectinib

Manufactured By : Genentech

Indications : ROS 1+VE mNSCLC

Medicine Description : Rozlytrek is a TRK, ROS1, and ALK inhibitor for solid tumors with NTRK fusions and ROS1-positive NSCLC. It blocks abnormal signaling pathways, shrinking tumors. Taken orally, it provides a tumor-agnostic approach. Side effects include dizziness, liver toxicity, cognitive impairment, and fatigue. Neurological and liver function monitoring are needed.

Product Introduction

Rozlytrek (Entrectinib) is a targeted anticancer treatment used for certain cancers driven by specific NTRK gene fusions or ROS1 gene alterations. It is used to treat adults and children with NTRK fusion-positive solid tumors that are locally advanced, metastatic, or where surgical removal is likely to cause severe complications, particularly when there are no satisfactory alternative treatments. It is also used in adults with ROS1-positive metastatic non-small cell lung cancer (NSCLC). By targeting these specific genetic alterations, Entrectinib helps control cancer growth and progression.

Rozlytrek (Entrectinib) works by inhibiting specific tyrosine kinases, including TRKA, TRKB, TRKC, ROS1, and ALK. Certain gene fusions or alterations can cause these proteins to remain abnormally active, sending signals that promote cancer cell growth and survival. Entrectinib blocks these abnormal signals, helping reduce the activity of pathways responsible for tumor growth. It can also reach the central nervous system, which may help target cancer that has spread to the brain.

Rozlytrek (Entrectinib) should be used exactly as prescribed by your doctor and continued for as long as recommended based on your condition and treatment response. Regular medical check-ups and tests may be required to monitor your heart function, liver function, uric acid levels, and overall health during treatment. Inform your doctor about all medical conditions and medicines, vitamins, herbal products, or supplements you are taking before starting treatment. Report unusual or worsening symptoms such as severe dizziness, confusion, shortness of breath, swelling, vision changes, or persistent muscle or joint pain promptly.

Uses Of Rozlytrek (Entrectinib)

Treatment of NTRK Fusion-Positive and ROS1-Positive Cancers

Benefits Of Rozlytrek

Rozlytrek (Entrectinib) is used to treat certain cancers with specific NTRK gene fusions or ROS1 alterations. It can help treat NTRK fusion-positive solid tumors that are locally advanced or metastatic, as well as ROS1-positive metastatic non-small cell lung cancer (NSCLC). By blocking abnormal activity of TRK and ROS1 proteins that contribute to cancer cell growth and survival, Rozlytrek (Entrectinib) helps slow tumor growth and disease progression. Its ability to enter the central nervous system may also help provide treatment for cancer that has spread to the brain.

Side Effects Of Rozlytrek (Entrectinib)

Some side effects of Rozlytrek (Entrectinib) may improve as the body adjusts to the treatment. Consult your doctor if any side effect persists, becomes severe, or causes concern.

Common Side Effects of Rozlytrek (Entrectinib)

  • Fatigue
  • Constipation
  • Changes in taste
  • Swelling (edema)
  • Dizziness
  • Diarrhea
  • Nausea
  • Weight gain
  • Vomiting
  • Increased uric acid levels
How To Use Rozlytrek

Take Rozlytrek (Entrectinib) exactly as prescribed by your doctor. It is usually taken once daily, with or without food, at approximately the same time each day. Swallow it whole with water and do not crush, chew, or break it. If you miss a dose, follow your doctor's instructions and do not take an extra dose unless advised. Continue treatment for as long as recommended by your healthcare professional.

How Rozlytrek (Entrectinib) Works

Rozlytrek (Entrectinib) is a targeted tyrosine kinase inhibitor that blocks the activity of proteins including TRKA, TRKB, TRKC, ROS1, and ALK. Certain genetic alterations can cause these proteins to become abnormally active and send signals that promote cancer cell growth and survival. Entrectinib blocks these abnormal signals, helping slow the growth and spread of cancer cells. It can also enter the central nervous system, which may help target cancer involving the brain.

Safety Advice

AlcoholCONSULT YOUR DOCTOR

Consult your doctor before consuming alcohol during treatment with Rozlytrek (Entrectinib).

PregnancyCONSULT YOUR DOCTOR

Rozlytrek may cause serious harm to an unborn baby. Inform your doctor if you are pregnant or planning to become pregnant. Use effective contraception during treatment as advised by your doctor.

BreastfeedingCONSULT YOUR DOCTOR

Breastfeeding is not recommended during treatment with Rozlytrek. Consult your doctor for guidance on when breastfeeding can be safely resumed.

DrivingCONSULT YOUR DOCTOR

Rozlytrek may cause dizziness, fatigue, blurred vision, or other effects that can affect your ability to drive safely. Avoid driving if your alertness or vision is affected.

KidneyCAUTION

Inform your doctor if you have kidney problems before starting treatment. Your doctor may recommend additional monitoring based on your kidney function.

LiverCAUTION

Tell your doctor if you have liver problems. Rozlytrek may affect liver function, so regular monitoring or dose adjustment may be required.

Quick Tips
  • Take Rozlytrek (Entrectinib) exactly as prescribed by your doctor and follow the recommended dosing schedule.
  • Take it at approximately the same time each day, with or without food.
  • Swallow it whole with water and do not crush, chew, or break it.
  • Attend regular medical check-ups and blood tests as recommended by your doctor.
  • Report dizziness, confusion, swelling, breathing difficulties, vision changes, or any new or worsening symptoms promptly.
  • Read More About - Rozlytrek (Entrectinib) from Pharma Five.
Faq

General Question

Rozlytrek Medicine (Entrectinib) is a prescription drug used to treat non-small cell lung cancer (NSCLC) and other cancers that have a specific genetic mutation (NTRK gene fusion) or ALK-positive NSCLC.

Rozlytrek Medicine works as a tyrosine kinase inhibitor (TKI), blocking the activity of specific proteins caused by genetic mutations in cancer cells, thereby preventing their growth and spread.

Doctors prescribe Rozlytrek Medicine for adults and children with solid tumors that have an NTRK gene fusion or for those with ALK-positive NSCLC who have not responded to other treatments.

Rozlytrek Medicine is taken orally in capsule form, usually once daily, with or without food. The exact dosage will depend on the patients condition and doctors recommendation.

Common side effects of Rozlytrek Medicine include fatigue, diarrhea, constipation, nausea, headache, and swelling in the hands or feet.

Yes, Rozlytrek Medicine may cause serious side effects such as liver problems, heart issues, and neurological symptoms. Seek immediate medical attention if you experience severe symptoms like chest pain or confusion.

Rozlytrek Medicine is typically taken as long as it remains effective and is well-tolerated. Your doctor will determine the appropriate duration of treatment based on your progress.

It is best to avoid alcohol while taking Rozlytrek Medicine, as alcohol can increase the risk of certain side effects like dizziness and liver toxicity.

No, Rozlytrek Medicine may harm an unborn baby. Women should avoid pregnancy while taking this medication and use effective contraception during treatment.

Yes, Rozlytrek Medicine may interact with other drugs, including antifungals, antibiotics, and certain anti-seizure medications. Be sure to inform your doctor about all the medications you are currently taking.

If you miss a dose of Rozlytrek Medicine, take it as soon as you remember, but skip it if the time for the next dose is near. Do not take two doses at once to make up for a missed dose.

Yes, Rozlytrek Medicine can be taken with or without food. However, taking it with food might help reduce stomach discomfort.

Avoid grapefruit, limit sun exposure, and ensure regular blood tests to monitor liver function and overall health during treatment.

Store Rozlytrek Medicine at room temperature, away from moisture and heat, and keep it out of reach of children.

Rozlytrek Medicine is available by prescription at pharmacies or through specialty drug providers. Consult your doctor for the best source. Pharma Five assists in its procurement.